Skip to main content
Top
Published in: Tumor Biology 4/2014

01-04-2014 | Research Article

The variant interleukin 1f7 rs3811047 G>A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population

Authors: Xu Wang, Jun Yin, Liang Zheng, Liming Wang, Yijun Shi, Weifeng Tang, Guowen Ding, Chao Liu, Ruiping Liu, Suocheng Chen, Haiyong Gu

Published in: Tumor Biology | Issue 4/2014

Login to get access

Abstract

To investigate the association between gastric cardiac adenocarcinoma (GCA) and six functional single nucleotide polymorphisms (SNPs) including interleukin 1A (IL1A) rs1800587 C>T, IL1B rs16944 G>A, IL1f7 rs3811047 G>A, IL3 rs40401 C>T, IL3 rs2073506 G>A, and IL7Rα rs6897932 A>G. We performed a hospital-based case–control study to evaluate the genetic effects of these SNPs. A total of 243 GCA cases and 476 controls were enrolled in this study. A custom-by-design 48-Plex SNPscanTM kit was used to determine the genotypes. The IL1f7 rs3811047 G>A polymorphism was significantly associated with a decreased risk of GCA either in the single locus analyses or the recessive genetic model. However, there was no significant association between the other five SNPs and GCA risk. These results elucidated that the functional polymorphism, IL1f7 rs3811047 G>A, might contribute to GCA susceptibility. However, the statistical power of our study was limited, large well-designed studies and further functional investigations are needed to confirm our findings.
Literature
1.
go back to reference Zhang L, Du C, Guo X, Yuan L, Niu W, Yu W, et al. Interleukin-8-251a/t polymorphism and helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of china. Mol Biol Rep. 2010;37:3983–9.PubMedCrossRef Zhang L, Du C, Guo X, Yuan L, Niu W, Yu W, et al. Interleukin-8-251a/t polymorphism and helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of china. Mol Biol Rep. 2010;37:3983–9.PubMedCrossRef
2.
go back to reference Hu S, Song QB, Yao PF, et al. No relationship between il-1b gene polymorphism and gastric acid secretion in younger healthy volunteers. World J Gastroenterol. 2005;11:6549–53.PubMed Hu S, Song QB, Yao PF, et al. No relationship between il-1b gene polymorphism and gastric acid secretion in younger healthy volunteers. World J Gastroenterol. 2005;11:6549–53.PubMed
3.
go back to reference Zhang W, Li C, Wang J, He C. Functional polymorphisms in fas/fasl system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma. Hepatogastroenterology. 2012;59:141–6.PubMedCrossRef Zhang W, Li C, Wang J, He C. Functional polymorphisms in fas/fasl system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma. Hepatogastroenterology. 2012;59:141–6.PubMedCrossRef
4.
go back to reference Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer. 2007;121:2373–80.PubMedCrossRef Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer. 2007;121:2373–80.PubMedCrossRef
5.
7.
go back to reference Smyth MJ, Cretney E, Kershaw MH, et al. Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004;202:275–93.PubMedCrossRef Smyth MJ, Cretney E, Kershaw MH, et al. Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004;202:275–93.PubMedCrossRef
8.
go back to reference Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 2002;54:82–6.PubMedCrossRef Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 2002;54:82–6.PubMedCrossRef
9.
go back to reference Wen AQ, Wang J, Feng K, et al. Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock. 2006;26:25–30.PubMedCrossRef Wen AQ, Wang J, Feng K, et al. Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock. 2006;26:25–30.PubMedCrossRef
10.
go back to reference Prasad KN, Nyati KK, Verma A, et al. Tumor necrosis factor-alpha polymorphisms and expression in guillain-barré syndrome. Hum Immunol. 2010;71:905–10.PubMedCrossRef Prasad KN, Nyati KK, Verma A, et al. Tumor necrosis factor-alpha polymorphisms and expression in guillain-barré syndrome. Hum Immunol. 2010;71:905–10.PubMedCrossRef
11.
go back to reference El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cance. Nature. 2000;404:398–402.PubMedCrossRef El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cance. Nature. 2000;404:398–402.PubMedCrossRef
12.
go back to reference Vincenzi B, Patti G, Galluzzo S, et al. Interleukin 1beta-511 t gene (il1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncol Rep. 2008;20:1213–20.PubMed Vincenzi B, Patti G, Galluzzo S, et al. Interleukin 1beta-511 t gene (il1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncol Rep. 2008;20:1213–20.PubMed
13.
go back to reference Dinorah NMC, Elvira GG, Reyes BL, et al. Association of il1b–511c/-31 t haplotype and helicobacter pylori vaca genotypes with gastric ulcer and chronic gastritis. BMC Gastroenterol. 2010;10:126–34.CrossRef Dinorah NMC, Elvira GG, Reyes BL, et al. Association of il1b–511c/-31 t haplotype and helicobacter pylori vaca genotypes with gastric ulcer and chronic gastritis. BMC Gastroenterol. 2010;10:126–34.CrossRef
14.
go back to reference Pan F, Liao F, Xia G, et al. Association of il-1f7 gene with suscepti-bility to human leukocyte antigen-b27 positive ankylosing spon-dylitis in Han Chinese population. Clin Chim Acta. 2010;411:124–6.PubMedCrossRef Pan F, Liao F, Xia G, et al. Association of il-1f7 gene with suscepti-bility to human leukocyte antigen-b27 positive ankylosing spon-dylitis in Han Chinese population. Clin Chim Acta. 2010;411:124–6.PubMedCrossRef
15.
go back to reference Pei B, Xu S, Liu T, et al. Associations of the il-1f7 gene polymorphisms with rheumatoid arthritis in Han Chinese population. Int J Immunogenet. 2012;40:199–203.PubMedCrossRef Pei B, Xu S, Liu T, et al. Associations of the il-1f7 gene polymorphisms with rheumatoid arthritis in Han Chinese population. Int J Immunogenet. 2012;40:199–203.PubMedCrossRef
16.
go back to reference Potvin S, Stip E, Sepehry AA, et al. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801–8.PubMedCrossRef Potvin S, Stip E, Sepehry AA, et al. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801–8.PubMedCrossRef
17.
go back to reference Slattery ML, Lundgreen A, Bondurant KL, et al. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis. 2011;32:1660–7.PubMedCentralPubMedCrossRef Slattery ML, Lundgreen A, Bondurant KL, et al. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis. 2011;32:1660–7.PubMedCentralPubMedCrossRef
18.
go back to reference Schweiger A, Stern D. Lohman IC, et a: Differences in proliferation of the hematopoietic cell line tf-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human il-3. J Allergy Clin Immunol. 2001;107:505–10.PubMedCrossRef Schweiger A, Stern D. Lohman IC, et a: Differences in proliferation of the hematopoietic cell line tf-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human il-3. J Allergy Clin Immunol. 2001;107:505–10.PubMedCrossRef
19.
go back to reference Booth DR, Arthur AT, Teutsch SM, et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med. 2005;83:822–30.PubMedCrossRef Booth DR, Arthur AT, Teutsch SM, et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med. 2005;83:822–30.PubMedCrossRef
20.
go back to reference Lundmark F, Duvefelt K, Lacobaeus E, et al. Variation in interleukin 7 receptor alpha chain (il7r) in fluences risk of multiple sclerosis. Nat Genet. 2007;39:1108–13.PubMedCrossRef Lundmark F, Duvefelt K, Lacobaeus E, et al. Variation in interleukin 7 receptor alpha chain (il7r) in fluences risk of multiple sclerosis. Nat Genet. 2007;39:1108–13.PubMedCrossRef
21.
go back to reference Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39:857–64.PubMedCentralPubMedCrossRef Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39:857–64.PubMedCentralPubMedCrossRef
22.
go back to reference Zheng L, Yin J, Wang L, Wang X, Shi Y, Shao A, et al. Interleukin 1b rs16944 G>A polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Clin Biochem. 2013;46:1469–73.PubMedCrossRef Zheng L, Yin J, Wang L, Wang X, Shi Y, Shao A, et al. Interleukin 1b rs16944 G>A polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Clin Biochem. 2013;46:1469–73.PubMedCrossRef
23.
go back to reference Cheng J, Zhang H, Zhuang C, et al. Peptidylarginine deiminase type 4 and methyl-cpg binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis. J Rheumatol. 2012;39:1159–65.PubMedCrossRef Cheng J, Zhang H, Zhuang C, et al. Peptidylarginine deiminase type 4 and methyl-cpg binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis. J Rheumatol. 2012;39:1159–65.PubMedCrossRef
25.
go back to reference Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, et al. Replication study of plce1 and c20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012;39:9105–11.PubMedCrossRef Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, et al. Replication study of plce1 and c20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012;39:9105–11.PubMedCrossRef
26.
go back to reference Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, et al. Mir-196a2 rs11614913 T>C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013;74:1199–205.PubMedCrossRef Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, et al. Mir-196a2 rs11614913 T>C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013;74:1199–205.PubMedCrossRef
27.
28.
29.
go back to reference Kumar S, Hanning CR, Brigham-Burke MR, et al. Interleukin-1f7b (il-1h4/il-1f7) is processed by caspase-1 and mature il-1f7b binds to the il-18 receptor but dose not induce ifn-gamma production. Cytokine. 2002;18:61–71.PubMedCrossRef Kumar S, Hanning CR, Brigham-Burke MR, et al. Interleukin-1f7b (il-1h4/il-1f7) is processed by caspase-1 and mature il-1f7b binds to the il-18 receptor but dose not induce ifn-gamma production. Cytokine. 2002;18:61–71.PubMedCrossRef
30.
go back to reference Pan G, Risser P, Mao W, et al. Il-1h, an interleukin 1-related protein that binds il-18 receptor/il-1rrp. Cytokine. 2001;13:1–7.PubMedCrossRef Pan G, Risser P, Mao W, et al. Il-1h, an interleukin 1-related protein that binds il-18 receptor/il-1rrp. Cytokine. 2001;13:1–7.PubMedCrossRef
31.
go back to reference Gao W, Kumar S, Lotze MT, et al. Innate immunity mediated by the cytokine il-1 homologue 4 (il-1h4/il-1f7) induces il-12-dependent adaptive and profound antitumor immunity. J Immunol Rev. 2003;170:107–13. Gao W, Kumar S, Lotze MT, et al. Innate immunity mediated by the cytokine il-1 homologue 4 (il-1h4/il-1f7) induces il-12-dependent adaptive and profound antitumor immunity. J Immunol Rev. 2003;170:107–13.
32.
go back to reference Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1b and interleukin-1 rn polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1604–17.PubMedCrossRef Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1b and interleukin-1 rn polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1604–17.PubMedCrossRef
33.
go back to reference Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, et al. Association of interleukin 1b gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut. 2003;52:1684–9.PubMedCentralPubMedCrossRef Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, et al. Association of interleukin 1b gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut. 2003;52:1684–9.PubMedCentralPubMedCrossRef
34.
go back to reference Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis. 2007;28:118–23.PubMedCrossRef Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis. 2007;28:118–23.PubMedCrossRef
Metadata
Title
The variant interleukin 1f7 rs3811047 G>A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population
Authors
Xu Wang
Jun Yin
Liang Zheng
Liming Wang
Yijun Shi
Weifeng Tang
Guowen Ding
Chao Liu
Ruiping Liu
Suocheng Chen
Haiyong Gu
Publication date
01-04-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1463-y

Other articles of this Issue 4/2014

Tumor Biology 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine